Optimus Healthcare Services, Inc. (OHCS) Financial Statements (2026 and earlier)

Company Profile

Business Address 1400 OLD WESTBURY ROAD, SUITE 306
WESTBURY, NY 11590
State of Incorp. FL
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100895
Cash and cash equivalent100751
Short-term investments  144
Receivables573525
Deferred costs  (0)
Other undisclosed current assets134306
Total current assets:8071,726
Noncurrent Assets
Operating lease, right-of-use asset224340
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization3956
Intangible asset, including goodwill, after accumulated amortization  818
Goodwill  816
Intangible asset, excluding goodwill, after accumulated amortization  3
Total noncurrent assets:2631,214
TOTAL ASSETS:1,0702,940
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,1981,320
Accounts payable1,154738
Accrued liabilities1,043582
Debt4,401145
Other liabilities 5 
Other undisclosed current liabilities1,43067
Total current liabilities:8,0341,533
Noncurrent Liabilities
Long-term debt and lease obligation  2,760
Long-term debt, excluding current maturities  2,760
Liabilities, other than long-term debt177290
Operating lease, liability175283
Program rights obligations 27
Total noncurrent liabilities:1773,050
Total liabilities:8,2114,582
Equity
Equity, attributable to parent, including:(7,138)(1,641)
Preferred stock  8
Common stock4038
Common stock, value, subscriptions 1 
Additional paid in capital22,94817,344
Accumulated deficit(30,134)(19,033)
Other undisclosed equity, attributable to parent81
Equity, attributable to noncontrolling interest(3)(1)
Total equity:(7,141)(1,643)
TOTAL LIABILITIES AND EQUITY:1,0702,940

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
Revenues1,4981,219
Cost of revenue(284)(263)
Gross profit:1,213956
Operating expenses(9,786)(9,022)
Operating loss:(8,573)(8,066)
Nonoperating expense(2,529)(1,985)
Investment income, nonoperating95(310)
Interest and debt expense(614)(218)
Loss from continuing operations before equity method investments, income taxes:(11,715)(10,269)
Other undisclosed income from continuing operations before income taxes614218
Loss from continuing operations before income taxes:(11,101)(10,051)
Income tax expense(2)(674)
Loss from continuing operations:(11,104)(10,725)
Other undisclosed net income2 
Net loss:(11,101)(10,725)
Net income (loss) attributable to noncontrolling interest(2)10,725
Other undisclosed net loss attributable to parent (10,725)
Net loss available to common stockholders, diluted:(11,104)(10,725)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
Net loss:(11,101)(10,725)
Comprehensive loss:(11,101)(10,725)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(2)10,725
Comprehensive loss, net of tax, attributable to parent:(11,104) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: